Prosecution Insights
Last updated: September 17, 2026
Application No. 17/844,239

ANTIMICROBIAL AND ANTIBACTERIAL THERMAL-REGULATING FABRIC FOR USE IN GARMENTS, WITHIN GARMENTS AND IN OTHER OBJECTS

Final Rejection §103
Filed
Jun 20, 2022
Priority
Jun 21, 2021 — provisional 63/213,057
Examiner
WAX, ROBERT A
Art Unit
1617
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
AG Thermal Products LLC
OA Round
2 (Final)
25%
Grant Probability
At Risk
3-4
OA Rounds
0m
Est. Remaining
29%
With Interview

Examiner Intelligence

Grants only 25% of cases
25%
Career Allowance Rate
27 granted / 107 resolved
-34.8% vs TC avg
Minimal +4% lift
Without
With
+3.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
13 currently pending
Career history
113
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
46.0%
+6.0% vs TC avg
§102
16.0%
-24.0% vs TC avg
§112
22.8%
-17.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 107 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Summary Claims 1-4,7-14 and 17-18 are pending in this office action. Claims 10, 11 and 14 are amended. Claims 5, 6, 15 and 16 are cancelled. All pending claims are under examination in this application. Priority The current application filed on June 20, 2022 claims domestic priority to provisional patent application 63/213,057 filed on June 21, 2021. In addition, the instant application serves as the priority document for PCT/US22/34211, filed June 21, 2022. Information Disclosure Statement Receipt of the Information Disclosure Statement filed on May 13, 2026 is acknowledged. A signed copy of the form PTO/SB/08 is attached to this office action. Response to Amendment Applicant’s response of May 13, 2026 has been received and entered into the application file. Applicant’s amendments to the abstract and claims 10, 11 and 14 have overcome the objections and rejection under 35 USC 112(b) from the nonfinal action mailed July 10, 2024. Response to Arguments Applicant’s arguments, see Remarks, filed May 13, 2026, with respect to the rejections of claims 1-18 under 35 USC 103 have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new ground(s) of rejection is made in view of Sweeney et al. in view of Patel. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-3, 7-14 and 17-18 are rejected under 35 U.S.C. 103 as being unpatentable over Sweeney et al. in view of Patel and Christo. Sweeney et al. teach a knitted glove made from a plurality of yarns. One yarn is antimicrobial, see paragraph [0034] and another type is thermal regulating yarn, see paragraph [0033]. Claim 12 lists many combinations of yarn types; the specific combination of antimicrobial and thermal regulating is not included. The antimicrobial yarns specifically named by Sweeney et al. are not made antimicrobial by inclusion of particles. Sweeney et al. do not disclose the antimicrobial particles of claims 1 and 4, nor do they disclose proportions or uses of the material other than gloves. Patel teaches antimicrobial yarn given that property by incorporating silver nanoparticles and discusses uses for the fabric other than gloves. Christo teaches antimicrobial glove that incorporates silver salts as the antimicrobial into the textile fibers, see paragraph [0041]. It would have been obvious to one of ordinary skill in the art, prior to the instant effective filing date, to use the silver salt nanoparticle-infused fiber of Christo as the antimicrobial fiber of Sweeney et al. with the expectation of providing an antimicrobial fiber. It would have been further obvious that the teachings of Sweeney et al. could be easily expanded to other uses for the glove fabric. With regard to the specific proportions of yarns, it is considered to be well within the ordinary level of skill in the art to determine the proportions, depending on the properties desired. Should specific proportions give rise to unexpectedly superior results, examiner invites applicant to demonstrate the same. Conclusion No claim is allowed. Applicant's submission of an information disclosure statement under 37 CFR 1.97(c) with the timing fee set forth in 37 CFR 1.17(p) on May 13, 2026 prompted the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 609.04(b). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Robert A. Wax whose telephone number is (571)272-0623. The examiner can normally be reached 8:00 AM -4:00 PM Monday - Friday. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Michener can be reached at (571) 272-1424. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Robert A Wax/Supervisory Patent Examiner, Art Unit 1615
Read full office action

Prosecution Timeline

Jun 20, 2022
Application Filed
Jul 10, 2024
Non-Final Rejection mailed — §103
Jan 16, 2025
Response after Non-Final Action
May 13, 2026
Response Filed
Sep 01, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12728147
COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASE COMPRISING HYDROLYSIS EXTRACT OF PULSATILLA KOREANA AND ANEMONE RADDEANA AS ACTIVE INGREDIENT
3y 9m to grant Granted Sep 08, 2026
Patent 12728084
COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND A GAMMA-BUTYROLACTONE AND/OR A GAMMA-BUTYROLACTAM
2y 4m to grant Granted Sep 08, 2026
Patent 12708597
HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION
3y 2m to grant Granted Aug 18, 2026
Patent 12693288
QUALITY CONTROL SUBSTANCE FOR USE IN THE ANALYSIS OF ERYTHROCYTES
2y 10m to grant Granted Jul 28, 2026
Patent 12667539
ORAL GUM COMPOSITION
3y 9m to grant Granted Jun 30, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
25%
Grant Probability
29%
With Interview (+3.7%)
3y 10m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 107 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month